Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells - PubMed (original) (raw)

doi: 10.1038/ni.2665. Epub 2013 Jul 21.

Anil Kumar, Gan Siok Wan, Gundimeda S Ramanjaneyulu, Marco Cavallari, Sary El Daker, Travis Beddoe, Alex Theodossis, Neal K Williams, Emma Gostick, David A Price, Dinish U Soudamini, Kong Kien Voon, Malini Olivo, Jamie Rossjohn, Lucia Mori, Gennaro De Libero

Affiliations

Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells

Stefano Vavassori et al. Nat Immunol. 2013 Sep.

Abstract

Human T cells that express a T cell antigen receptor (TCR) containing γ-chain variable region 9 and δ-chain variable region 2 (Vγ9Vδ2) recognize phosphorylated prenyl metabolites as antigens in the presence of antigen-presenting cells but independently of major histocompatibility complex (MHC), the MHC class I-related molecule MR1 and antigen-presenting CD1 molecules. Here we used genetic approaches to identify the molecule that binds and presents phosphorylated antigens. We found that the butyrophilin BTN3A1 bound phosphorylated antigens with low affinity, at a stoichiometry of 1:1, and stimulated mouse T cells with transgenic expression of a human Vγ9Vδ2 TCR. The structures of the BTN3A1 distal domain in complex with host- or microbe-derived phosphorylated antigens had an immunoglobulin-like fold in which the antigens bound in a shallow pocket. Soluble Vγ9Vδ2 TCR interacted specifically with BTN3A1-antigen complexes. Accordingly, BTN3A1 represents an antigen-presenting molecule required for the activation of Vγ9Vδ2 T cells.

PubMed Disclaimer

Comment in

Similar articles

Cited by

References

    1. Clin Exp Immunol. 2004 Jun;136(3):472-82 - PubMed
    1. Eur J Immunol. 1997 Nov;27(11):2812-21 - PubMed
    1. Immunity. 1998 Mar;8(3):331-40 - PubMed
    1. FASEB J. 2000 Sep;14(12):1669-70 - PubMed
    1. Eur J Immunol. 2011 Dec;41(12):3443-54 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources